ホーム
マーケット
チャート&アイデア
Algo
ニュース
ストア
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
Heatmap
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
THQ
#6473
abrdn Healthcare Opportunities Fund
18.3
4
USD
+2.06%
セクター:
金融
ベース:
USD
利益通貨:
USD
日中レンジ
1年のレンジ
1日の変化
+2.06%
月次変化
+2.46%
6か月変化
+2.34%
1年の変化
-4.88%
以前の終値
17.9
7
始値
18.3
2
Bid
Ask
安値
18.2
8
High
18.3
5
ボリューム
5
マーケット
株
金融
THQ
チャート全体を表示
主要保有銘柄
Market Value
Shares
Weight %
LLY
Eli Lilly & Co
62.9 M
82.5 K
8.5%
MRK
Merck & Co Inc
34.6 M
412.8 K
4.7%
Medtronic PLC
33.3 M
349.7 K
4.5%
ISRG
Intuitive Surgical Inc
27.0 M
60.4 K
3.6%
DHR
Danaher Corp
25.8 M
130.1 K
3.5%
TMO
Thermo Fisher Scientific Inc
23.5 M
48.4 K
3.2%
BDX
Becton Dickinson & Co
21.7 M
115.7 K
2.9%
ZTS
Zoetis Inc
21.2 M
144.6 K
2.9%
BSX
Boston Scientific Corp
18.9 M
193.3 K
2.5%
BMY
Bristol-Myers Squibb Co
17.8 M
394.7 K
2.4%
HUM
Humana Inc
17.0 M
65.4 K
2.3%
ELV
Elevance Health Inc
16.7 M
51.6 K
2.3%
CYTK
Cytokinetics Inc
16.5 M
300.3 K
2.2%
SRPT
Sarepta Therapeutics Inc
14.3 M
743.4 K
1.9%
SPRY
ARS Pharmaceuticals Inc
13.4 M
1.3 M
1.8%
SYK
Stryker Corp
13.0 M
35.2 K
1.8%
OHI
Omega Healthcare Investors Inc
12.6 M
297.9 K
1.7%
INSP
Inspire Medical Systems Inc
12.3 M
165.8 K
1.7%
SBRA
Sabra Health Care REIT Inc
11.7 M
626.9 K
1.6%
DOC
Healthpeak Properties Inc
10.9 M
567.7 K
1.5%
ニュース
THQ: 13% Yield That Captures The Growth Of The Weight Loss Market
Never Cutters, Part 2: 5 More High Yield CEFs That Have Never Cut The Distribution
7 High-Yield CEFs That Have Never Cut The Distribution In 10 Years Plus
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary
Switching From THQ To BME Despite The Yield (NYSE:THQ)
This Is How I Would Invest $100,000 In 2026
BME: Monthly Income With Upside From The Out-Of-Favor Healthcare Sector (NYSE:BME)
BMEZ: NAV Decline Continues And Underperforms Peers (BMEZ)
HQH: Severely Underperforms Peers (NYSE:HQH)
THQ: A CEF That Distributes 'Uncertainty' Across The Healthcare Segment (NYSE:THQ)
THQ: Outperforms Peers But Has Limited Growth Potential
Wall Street Week Ahead